nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepyramine—CYP2D6—Parkinson's disease	0.981	1	CbGaD
Mepyramine—Chlorphenamine—SLC6A3—Parkinson's disease	0.000922	0.0922	CrCbGaD
Mepyramine—Rosiglitazone—CYP2D6—Parkinson's disease	0.000908	0.0908	CrCbGaD
Mepyramine—Tripelennamine—CYP2D6—Parkinson's disease	0.000834	0.0834	CrCbGaD
Mepyramine—Carbinoxamine—CYP2E1—Parkinson's disease	0.000777	0.0776	CrCbGaD
Mepyramine—Brompheniramine—CYP2E1—Parkinson's disease	0.000673	0.0672	CrCbGaD
Mepyramine—Methotrimeprazine—DRD3—Parkinson's disease	0.00067	0.0669	CrCbGaD
Mepyramine—Methotrimeprazine—DRD1—Parkinson's disease	0.000657	0.0657	CrCbGaD
Mepyramine—Diltiazem—CYP2D6—Parkinson's disease	0.000581	0.0581	CrCbGaD
Mepyramine—Carbinoxamine—CYP2D6—Parkinson's disease	0.00057	0.057	CrCbGaD
Mepyramine—Brompheniramine—CYP2D6—Parkinson's disease	0.000494	0.0494	CrCbGaD
Mepyramine—Chlorphenamine—CYP2D6—Parkinson's disease	0.000485	0.0485	CrCbGaD
Mepyramine—Methotrimeprazine—DRD2—Parkinson's disease	0.000463	0.0463	CrCbGaD
Mepyramine—Methotrimeprazine—CYP2E1—Parkinson's disease	0.000446	0.0446	CrCbGaD
Mepyramine—Orphenadrine—CYP2E1—Parkinson's disease	0.000424	0.0424	CrCbGaD
Mepyramine—Diltiazem—ABCB1—Parkinson's disease	0.000415	0.0415	CrCbGaD
Mepyramine—Methotrimeprazine—HTR2A—Parkinson's disease	0.000358	0.0358	CrCbGaD
Mepyramine—Methotrimeprazine—CYP2D6—Parkinson's disease	0.000327	0.0327	CrCbGaD
Mepyramine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000242	0.0281	CbGpPWpGaD
Mepyramine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000227	0.0265	CbGpPWpGaD
Mepyramine—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000226	0.0263	CbGpPWpGaD
Mepyramine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000222	0.0259	CbGpPWpGaD
Mepyramine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000182	0.0211	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—HTR1A—Parkinson's disease	0.000179	0.0208	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD1—Parkinson's disease	0.000173	0.0201	CbGpPWpGaD
Mepyramine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000167	0.0195	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD3—Parkinson's disease	0.000167	0.0195	CbGpPWpGaD
Mepyramine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000167	0.0194	CbGpPWpGaD
Mepyramine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000158	0.0184	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—HTR7—Parkinson's disease	0.000151	0.0176	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—DRD2—Parkinson's disease	0.000151	0.0176	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.00015	0.0175	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000145	0.0169	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000141	0.0164	CbGpPWpGaD
Mepyramine—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.00014	0.0163	CbGpPWpGaD
Mepyramine—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000135	0.0157	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000127	0.0148	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000127	0.0148	CbGpPWpGaD
Mepyramine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000119	0.0139	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.00011	0.0128	CbGpPWpGaD
Mepyramine—SLC22A4—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00011	0.0128	CbGpPWpGaD
Mepyramine—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000106	0.0123	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000105	0.0122	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000105	0.0122	CbGpPWpGaD
Mepyramine—SLC22A4—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000101	0.0118	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	9.87e-05	0.0115	CbGpPWpGaD
Mepyramine—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	8.9e-05	0.0104	CbGpPWpGaD
Mepyramine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	8.56e-05	0.00996	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	8.53e-05	0.00993	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	8.36e-05	0.00973	CbGpPWpGaD
Mepyramine—SLC22A5—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	8.25e-05	0.0096	CbGpPWpGaD
Mepyramine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	7.97e-05	0.00928	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	7.9e-05	0.0092	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	7.9e-05	0.0092	CbGpPWpGaD
Mepyramine—SLC22A5—SLC-mediated transmembrane transport—CP—Parkinson's disease	7.59e-05	0.00884	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	7.48e-05	0.00871	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	7.31e-05	0.00851	CbGpPWpGaD
Mepyramine—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	7.2e-05	0.00838	CbGpPWpGaD
Mepyramine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	6.93e-05	0.00807	CbGpPWpGaD
Mepyramine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	6.49e-05	0.00755	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	6.05e-05	0.00704	CbGpPWpGaD
Mepyramine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	5.81e-05	0.00676	CbGpPWpGaD
Mepyramine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	5.74e-05	0.00668	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.58e-05	0.00649	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	5.57e-05	0.00648	CbGpPWpGaD
Mepyramine—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	5.41e-05	0.0063	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	5.41e-05	0.00629	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—CP—Parkinson's disease	5.13e-05	0.00597	CbGpPWpGaD
Mepyramine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	4.71e-05	0.00548	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	4.71e-05	0.00548	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	4.39e-05	0.00511	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	4.31e-05	0.00501	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.19e-05	0.00488	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	4.13e-05	0.00481	CbGpPWpGaD
Mepyramine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	4.08e-05	0.00474	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	3.97e-05	0.00463	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	3.93e-05	0.00457	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	3.9e-05	0.00453	CbGpPWpGaD
Mepyramine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	3.88e-05	0.00451	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—CP—Parkinson's disease	3.86e-05	0.00449	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	3.78e-05	0.0044	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	3.68e-05	0.00429	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.66e-05	0.00426	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	3.59e-05	0.00417	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.51e-05	0.00409	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	3.49e-05	0.00406	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	3.45e-05	0.00401	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	3.41e-05	0.00396	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	3.33e-05	0.00388	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	3.28e-05	0.00382	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	3.23e-05	0.00375	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	3.15e-05	0.00366	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.05e-05	0.00355	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	3.05e-05	0.00355	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	3.02e-05	0.00352	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	2.95e-05	0.00344	CbGpPWpGaD
Mepyramine—SLC22A4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.93e-05	0.00341	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	2.92e-05	0.00339	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	2.92e-05	0.00339	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	2.91e-05	0.00339	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	2.86e-05	0.00332	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	2.86e-05	0.00332	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	2.85e-05	0.00332	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	2.76e-05	0.00322	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.75e-05	0.0032	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	2.7e-05	0.00314	CbGpPWpGaD
Mepyramine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	2.64e-05	0.00308	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.64e-05	0.00307	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	2.61e-05	0.00304	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	2.59e-05	0.00302	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	2.5e-05	0.00291	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	2.5e-05	0.00291	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	2.5e-05	0.00291	CbGpPWpGaD
Mepyramine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.47e-05	0.00287	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	2.38e-05	0.00277	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	2.36e-05	0.00275	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.3e-05	0.00267	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	2.25e-05	0.00262	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	2.22e-05	0.00258	CbGpPWpGaD
Mepyramine—SLC22A5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.2e-05	0.00256	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	2.17e-05	0.00253	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	2.16e-05	0.00252	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	2.14e-05	0.00249	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	2.1e-05	0.00245	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	2.07e-05	0.00241	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	2.06e-05	0.0024	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	2.06e-05	0.0024	CbGpPWpGaD
Mepyramine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	2.05e-05	0.00238	CbGpPWpGaD
Mepyramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	2.04e-05	0.00238	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	2.04e-05	0.00237	CbGpPWpGaD
Mepyramine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	2.04e-05	0.00237	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	2.03e-05	0.00236	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	2e-05	0.00233	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	1.94e-05	0.00226	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	1.9e-05	0.00221	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	1.9e-05	0.00221	CbGpPWpGaD
Mepyramine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	1.9e-05	0.00221	CbGpPWpGaD
Mepyramine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	1.87e-05	0.00218	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	1.85e-05	0.00216	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	1.84e-05	0.00214	CbGpPWpGaD
Mepyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	1.75e-05	0.00204	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	1.72e-05	0.00201	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	1.69e-05	0.00196	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	1.69e-05	0.00196	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	1.68e-05	0.00196	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	1.57e-05	0.00182	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	1.54e-05	0.0018	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	1.52e-05	0.00177	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	1.47e-05	0.00171	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	1.35e-05	0.00157	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ND3—Parkinson's disease	1.35e-05	0.00157	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	1.35e-05	0.00157	CbGpPWpGaD
Mepyramine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	1.33e-05	0.00155	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	1.33e-05	0.00155	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	1.28e-05	0.00149	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	1.27e-05	0.00148	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	1.26e-05	0.00147	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—OMD—Parkinson's disease	1.26e-05	0.00147	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	1.25e-05	0.00146	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	1.23e-05	0.00143	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.2e-05	0.0014	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	1.19e-05	0.00138	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	1.15e-05	0.00134	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	1.15e-05	0.00133	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.14e-05	0.00133	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	1.14e-05	0.00132	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	1.12e-05	0.0013	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.11e-05	0.00129	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PENK—Parkinson's disease	1.09e-05	0.00127	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MAG—Parkinson's disease	1.09e-05	0.00127	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	1.08e-05	0.00126	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	1.08e-05	0.00125	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	1.08e-05	0.00125	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GBA—Parkinson's disease	1.02e-05	0.00119	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—DBH—Parkinson's disease	1.02e-05	0.00119	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.02e-05	0.00119	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	1.01e-05	0.00117	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	9.95e-06	0.00116	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	9.77e-06	0.00114	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	9.77e-06	0.00114	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	9.35e-06	0.00109	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	9.25e-06	0.00108	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	8.61e-06	0.001	CbGpPWpGaD
Mepyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	8.2e-06	0.000955	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	8.11e-06	0.000943	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	7.86e-06	0.000915	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	7.82e-06	0.00091	CbGpPWpGaD
Mepyramine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	7.53e-06	0.000877	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—DDC—Parkinson's disease	7.48e-06	0.000871	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—INSR—Parkinson's disease	7.26e-06	0.000844	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	7.07e-06	0.000822	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—FGB—Parkinson's disease	6.86e-06	0.000798	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	6.84e-06	0.000796	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	6.82e-06	0.000794	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	6.72e-06	0.000782	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	6.59e-06	0.000767	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	6.38e-06	0.000742	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	6.36e-06	0.00074	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MAOB—Parkinson's disease	6.3e-06	0.000733	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	5.96e-06	0.000693	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	5.77e-06	0.000671	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	5.77e-06	0.000671	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	4.84e-06	0.000563	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	4.68e-06	0.000544	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	4.62e-06	0.000538	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CTGF—Parkinson's disease	4.59e-06	0.000535	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4.28e-06	0.000498	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—NGF—Parkinson's disease	4.25e-06	0.000494	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.23e-06	0.000493	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—TH—Parkinson's disease	4.17e-06	0.000485	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	4.04e-06	0.00047	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.01e-06	0.000466	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.76e-06	0.000437	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—COMT—Parkinson's disease	3.55e-06	0.000413	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.53e-06	0.000411	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.52e-06	0.00041	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.48e-06	0.000405	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.34e-06	0.000389	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.24e-06	0.000378	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—INS—Parkinson's disease	3.21e-06	0.000374	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.11e-06	0.000362	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.87e-06	0.000334	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—APOE—Parkinson's disease	2.67e-06	0.000311	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.39e-06	0.000278	CbGpPWpGaD
Mepyramine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2.37e-06	0.000276	CbGpPWpGaD
Mepyramine—CYP2D6—Metabolism—INS—Parkinson's disease	2.28e-06	0.000265	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.2e-06	0.000256	CbGpPWpGaD
Mepyramine—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.4e-06	0.000163	CbGpPWpGaD
